| FDKVX | FNGLX | FDKVX / FNGLX | |
| Total Expense Ratio | 0.68 | 0.46 | 148% |
| Annual Report Gross Expense Ratio | 0.68 | 0.46 | 148% |
| Fund Existence | 11 years | 9 years | - |
| Gain YTD | 20.550 | 18.723 | 110% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.8B | 830M | 940% |
| Annual Yield % from dividends | 0.85 | 1.33 | 64% |
| Returns for 1 year | 15.20 | 13.83 | 110% |
| Returns for 3 years | 57.07 | 55.45 | 103% |
| Returns for 5 years | 33.91 | 33.12 | 102% |
| Returns for 10 years | 90.08 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTDX | 166.16 | 0.92 | +0.56% |
| Franklin Biotechnology Discovery C | |||
| LGCWX | 20.46 | 0.08 | +0.39% |
| Lord Abbett Global Equity R6 | |||
| GBLFX | 42.22 | 0.12 | +0.29% |
| American Funds Global Balanced F2 | |||
| TNXAX | 10.84 | 0.02 | +0.17% |
| 1290 Loomis Sayles Multi-Asset Income A | |||
| ALARX | 59.16 | 0.01 | +0.02% |
| Alger Capital Appreciation Instl I | |||